Huajiang Wei

Title: Innovations of Huajiang Wei in Nucleic Acid Testing

Introduction

Huajiang Wei is a notable inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of testing methods for nucleic acid binding proteins. His innovative approach has the potential to enhance the accuracy and efficiency of biological testing.

Latest Patents

Huajiang Wei holds 1 patent for a testing method of nucleic acid binding protein based on biochip technology. This method involves several steps: first, a variety of solutions containing nucleic acid captured probes are introduced into a biological sample that includes multiple nucleic acid binding proteins to be tested. This results in the formation of nucleic acid captured probe-nucleic acid binding protein complexes. Next, these complexes are separated, and the nucleic acid captured probes are recovered. The recovered probes are then hybridized with a range of single-strand blotting probes on a biochip substrate, where the sequence of the blotting probe complements that of the nucleic acid captured probe. Finally, the results of the hybridization are detected, providing valuable insights into the presence of specific nucleic acid binding proteins.

Career Highlights

Throughout his career, Huajiang Wei has worked with prominent organizations such as Capitalbio Corporation and Tsinghua University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Huajiang Wei has collaborated with notable colleagues, including Wei Shao and Yongchao Zhao. These partnerships have further enriched his research and development efforts in the biotechnology sector.

Conclusion

Huajiang Wei's innovative work in nucleic acid testing exemplifies the advancements being made in biotechnology. His contributions are paving the way for more effective diagnostic methods in the medical field.